BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 12093899)

  • 21. Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC, K-ras, and p53 genes.
    Chiang JM; Wu Chou YH; Ma SC; Chen JR
    Virchows Arch; 2004 Nov; 445(5):465-71. PubMed ID: 15449054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
    Shiomori K; Shimada S; Marutsuka T; Hatayama I; Ogawa M
    Int J Oncol; 2003 Jan; 22(1):65-74. PubMed ID: 12469186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
    Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
    Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular detection of genetic alterations in the serum of colorectal cancer patients.
    Hibi K; Robinson CR; Booker S; Wu L; Hamilton SR; Sidransky D; Jen J
    Cancer Res; 1998 Apr; 58(7):1405-7. PubMed ID: 9537240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
    Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
    Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
    Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
    Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
    Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
    Etienne-Grimaldi MC; Formento JL; Francoual M; François E; Formento P; Renée N; Laurent-Puig P; Chazal M; Benchimol D; Delpero JR; Letoublon C; Pezet D; Seitz JF; Milano G
    Clin Cancer Res; 2008 Aug; 14(15):4830-5. PubMed ID: 18676755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of cycling gradient capillary electrophoresis to detection of APC, K-ras, and DCC point mutations in patients with sporadic colorectal tumors.
    Minarik M; Minarikova L; Hrabikova M; Minarikova P; Hrabal P; Zavoral M
    Electrophoresis; 2004 Apr; 25(7-8):1016-21. PubMed ID: 15095442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
    Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations.
    Prall F; Ostwald C
    Hum Pathol; 2007 Nov; 38(11):1696-702. PubMed ID: 17707462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of genetic disorders of cancer of the rectum: differences in relation to cancer of the colon].
    Rebischung C; Laurent-Puig P; Gerard JP; Thomas G; Hamelin R
    Gastroenterol Clin Biol; 1998; 22(8-9):679-87. PubMed ID: 9823556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
    Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
    Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas.
    Sakai Y; Yanagisawa A; Shimada M; Hidaka E; Seki M; Tada Y; Harada T; Saisho H; Kato Y
    Hum Pathol; 2000 Jul; 31(7):795-803. PubMed ID: 10923915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa.
    Morris RG; Curtis LJ; Romanowski P; Hardcastle JD; Jenkins DA; Robinson M; Wyllie AH; Bird CC
    J Pathol; 1996 Dec; 180(4):357-63. PubMed ID: 9014854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple detection of genetic alterations in tumors and stool.
    Rengucci C; Maiolo P; Saragoni L; Zoli W; Amadori D; Calistri D
    Clin Cancer Res; 2001 Mar; 7(3):590-3. PubMed ID: 11297253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.